H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-15,CFO,BLOCH KATHLEEN P. ,卖出,11176普通股, $8.25
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-15,CFO,BLOCH KATHLEEN P. ,期权,11176普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-13,CFO,BLOCH KATHLEEN P. ,卖出,1104普通股, $8.25
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-03-13,CFO,BLOCH KATHLEEN P. ,期权,1104普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-03-14 AccNo: 0001144204-18-014684 Size: 255 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-08 AccNo: 0001144204-18-013618 Size: 6 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-03-05 AccNo: 0001144204-18-012645 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2018-03-08 盘后 披露财报,预期EPS -0.1 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-01-16,COO,Capponi Vincent ,期权,44000普通股, $6.25
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-01-12,CFO,BLOCH KATHLEEN P. ,卖出,12400普通股, $7.75